SCHEMBL24348976

SCHEMBL24348976

Cc1nc(COc2ncc(C(=O)O)cn2)sc1-c1cccc(-c2cc(F)c3nn[nH]c3c2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BPGM P07738 6/20 0.52
▸ GPR52 Q9Y2T5 2/20 0.35
▸ PPARD Q03181 9/20 0.35
▸ MRGPRX4 Q96LA9 1/20 0.33
▸ PTGER4 P35408 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ CDC7 O00311 1/20 0.32
▸ PLK4 O00444 1/20 0.32
▸ DYRK3 O43781 1/20 0.32
▸ ROCK2 O75116 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ ROS1 P08922 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ PRKACA P17612 1/20 0.32
▸ RPS6KB1 P23443 1/20 0.32
▸ MARK3 P27448 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ AKT1 P31749 1/20 0.32
▸ MAPK9 P45984 1/20 0.32
▸ CSNK1A1 P48729 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24349408 0.90 BPGM (0.64) BPGMPPARDKDM4ECDC7PLK4
SCHEMBL24348054 0.88 BPGM (0.55) BPGMPPARDKDM4ECDC7PLK4
SCHEMBL26704310 0.88 BPGM (0.46) BPGMGPR52PPARDKDM4ECDC7
SCHEMBL24348056 0.87 BPGM (0.54) BPGMKDM4ECDC7PLK4DYRK3
SCHEMBL24348060 0.87 BPGM (0.54) BPGMPPARDKDM4ECDC7PLK4
SCHEMBL24348977 0.87 BPGM (0.54) BPGMKDM4ECDC7PLK4DYRK3
SCHEMBL26704320 0.85 BPGM (0.61) BPGMGPR52PPARDMRGPRX4PTGER4
SCHEMBL24349278 0.83 BPGM (0.44) BPGMGPR52PPARDKDM4ECDC7
SCHEMBL24349263 0.83 BPGM (0.49) BPGMKDM4ECDC7PLK4DYRK3
SCHEMBL24349240 0.82 BPGM (0.47) BPGMGPR52PPARDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022056449-A1 COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE GENZYME CORPORATION (US) 2022-03-17 — — WO disclosed
Send feedback